Sign in to fuzzto save your conversations, follow your research and come back anytime.
Pfizer
SectorHealthcare
Pfizer Limited is an Indian pharmaceutical company engaged in manufacturing, marketing, trading, and exporting pharmaceutical products. It has a manufacturing facility in Goa and works with contract manufacturers across India. The company offers a diverse portfolio of products including vaccines, anti-infectives, cardiac medications, pain relief, maternal nutrition, gastrointestinal treatments, contraceptives, anti-inflammatories, and respiratory medicines. Pfizer's key focus areas include vaccines, with Prevenar 13 for pneumococcal prevention, and inflammation and immunology treatments for chronic immune system diseases. The company has undergone several mergers, acquisitions, and divestments over the years, including the merger with Wyeth Limited in 2014 and the sale of certain established medicine brands to Mylan Pharmaceuticals in 2022.
In the news
Trump's drug-pricing deals reveal Big Pharma wins over patient benefits
Pune ITAT rules ₹65.21 lakh Pfizer VRS payout not taxable
Pfizer Q2 Beats Estimates, Raises Revenue Forecast to $60.5B-$62.5B
ICICI Securities recommends Pfizer buy with ₹6000 target
Pfizer, Anthropic Lead AI Healthcare Revolution
Pfizer beats Q1 estimates, sees growth boost from patent wins
Pfizer shares drop 3.60% on Q4 loss, lower 2026 outlook
Pfizer Leads Big Pharma M&A Race Amid $200B Patent Cliff
Company insights, generated from the most recent coverage.
Pfizer's brand integrity at risk as counterfeit EMBLAVEO vials bearing its name were seized in Bidadi repacking racket, highlighting supply chain vulnerability to label forgery.
Karnataka FDA suspension of Pfizer's Nelamangala depot halts sales in a key market, risking immediate revenue loss and market share erosion to competitors. This compounds headwinds from the recent Minipress XL discontinuation, despite Q1 FY27 revenue growth of 8.3%.
₹85.74 crore tax demand for FY2022-23 adds to near-term balance sheet headwinds alongside product exits.